Stage IVB Lung Cancer AJCC v8 Recruiting Phase 0 Trials for Brigatinib (DB12267)

IndicationStatusPhase
DBCOND0111251 (Stage IVB Lung Cancer AJCC v8)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03707938Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerTreatment